Growing community of inventors

Holte, Denmark

Ulla Mandel

Average Co-Inventor Count = 5.58

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 35

Ulla MandelHenrik Clausen (8 patents)Ulla MandelJoyce Taylor-Papadimitriou (5 patents)Ulla MandelJoy Burchell (5 patents)Ulla MandelAnne Louise Sørensen (5 patents)Ulla MandelMads Agervig Tarp (5 patents)Ulla MandelEric Paul Bennett (3 patents)Ulla MandelHans H Wandall (3 patents)Ulla MandelJohannes Wirenfeldt Vad Pedersen (3 patents)Ulla MandelHenrik Clausen (1 patent)Ulla MandelAnne Louise Sorensen (1 patent)Ulla MandelUlla Mandel (8 patents)Henrik ClausenHenrik Clausen (52 patents)Joyce Taylor-PapadimitriouJoyce Taylor-Papadimitriou (5 patents)Joy BurchellJoy Burchell (5 patents)Anne Louise SørensenAnne Louise Sørensen (5 patents)Mads Agervig TarpMads Agervig Tarp (5 patents)Eric Paul BennettEric Paul Bennett (7 patents)Hans H WandallHans H Wandall (6 patents)Johannes Wirenfeldt Vad PedersenJohannes Wirenfeldt Vad Pedersen (3 patents)Henrik ClausenHenrik Clausen (4 patents)Anne Louise SorensenAnne Louise Sorensen (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Cancer Research Technology Limited (5 from 263 patents)

2. Københavns Universitet (4 from 27 patents)

3. Go Therapeutics, Inc. (3 from 7 patents)

4. Kobenhavns Univerrsitet (1 from 1 patent)

5. Kobenhavns Universitet (19 patents)


8 patents:

1. 11860165 - CORE3-MUC1 binding polypeptides and uses thereof

2. 11067578 - Tn-MUC4 binding polypeptides and uses thereof

3. 10919973 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

4. 10139414 - Tn-MUC4 binding polypeptides and uses thereof

5. 10017576 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

6. 9359436 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

7. 8912311 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

8. 8440798 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…